A Study of MDX-1106 to Treat Patients With Hepatitis C Infection
NCT00703469
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
MDX1106-02
DRUG:
Placebo
Sponsor
Bristol-Myers Squibb